| Literature DB >> 30127284 |
Kylie Mason1, Kirstin Lindberg2, Deborah Read3, Barry Borman4.
Abstract
Developing environmental health indicators is challenging and applying a conceptual framework and indicator selection criteria may not be sufficient to prioritise potential indicators to monitor. This study developed a new approach for prioritising potential environmental health indicators, using the example of the indoor environment for New Zealand. A three-stage process of scoping, selection, and design was implemented. A set of potential indicators (including 4 exposure indicators and 20 health indicators) were initially identified and evaluated against indicator selection criteria. The health indicators were then further prioritised according to their public health impact and assessed by the five following sub-criteria: number of people affected (based on environmental burden of disease statistics); severity of health impact; whether vulnerable populations were affected and/or large inequalities were apparent; whether the indicator related to multiple environmental exposures; and policy relevance. Eight core indicators were ultimately selected, as follows: living in crowded households, second-hand smoke exposure, maternal smoking at two weeks post-natal, asthma prevalence, asthma hospitalisations, lower respiratory tract infection hospitalisations, meningococcal disease notifications, and sudden unexpected death in infancy (SUDI). Additionally, indicators on living in damp and mouldy housing and children's injuries in the home, were identified as potential indicators, along with attributable burden indicators. Using public health impact criteria and an environmental burden of disease approach was valuable in prioritising and selecting the most important health impacts to monitor, using robust evidence and objective criteria.Entities:
Keywords: attributable burden; environmental burden of disease; environmental health indicators; public health impact
Mesh:
Year: 2018 PMID: 30127284 PMCID: PMC6121674 DOI: 10.3390/ijerph15081786
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Process for developing a set of environmental health indicators. Source: Adapted from Briggs [2].
Indicator selection criteria for New Zealand environmental health indicators.
| Indicator Selection Criteria | Explanation |
|---|---|
| Data availability | Indicator must have data that can be easily and reliably extracted. |
| Scientifically valid | Indicator must have an established, scientifically sound link to the environmental health issue. |
| Sensitive | Indicator should respond relatively quickly and noticeably to changes but not show false movements. |
| Consistent | Indicator should be consistent with those used in other indicator programmes (including internationally) so comparisons can be made. |
| Comparable | Indicator should be consistent to allow comparisons over time. |
| Methodologically sound measurement | Indicator measurement needs to be methodologically sound. |
| Intelligible and easily interpreted | Indicator should be sufficiently simple to be interpreted in practice and be intuitive in the sense that it is obvious what the indicator is measuring. |
| Able to be disaggregated | Indicator needs to be able to be broken down into population subgroups or areas of particular interest, such as ethnic groups or regional areas. |
| Timely | Data needs to be collected and reported regularly and frequently to ensure it is reflecting current and not historical trends. |
Source: Based on the indicator selection criteria published by the Advisory Committee on Official Statistics [9].
Public health impact criteria for environmental health indicators.
| Public Health Impact Selection Criteria | Explanation |
|---|---|
| Public health impact | Indicator needs to relate to an environmental health issue of significant public health impact to New Zealand. This health impact may include affecting a large number of people, a vulnerable population, or Māori health; or having substantial policy relevance. |
| (i) Affecting a large number of people | Priority should be given to health effects affecting larger numbers of people (i.e., with a higher burden of disease attributable to the environmental exposure (e.g., measured as deaths, hospitalisations, or disability-adjusted life years (DALYs))), within the country/area of interest. |
| (ii) Severity of impact | Priority should be given to health conditions with severe impacts, such as severity of illness, long-term repercussions (such as disability or long-term illness), and/or risk of death. |
| (iii) Affecting vulnerable populations and/or having large inequalities | Priority should be given to health effects that particularly affect vulnerable population groups and/or have large health inequalities. |
| (iv) Relating to multiple exposures or health effects | Priority should be given to health indicators that link to multiple environmental exposures. |
| (v) Relevant to policy | Priority should be given to indicators where there is potential for policy actions about the environmental exposure to make a difference; and/or the issue is of current policy interest. |
Figure 2The multiple exposures multiple effects (MEME) framework, applied to the indoor environment. Source: Adapted from Briggs [2]. SUDI: sudden unexpected death in infancy.
Environmental exposures and related health effects, for the indoor environment.
| Environmental Exposure | Pathway | People Exposed | Health Effects—Causal (Level 1) | Health Effects—Suggestive (Level 2) |
|---|---|---|---|---|
| Household crowding | Household crowding | Children living in crowded households | GastroenteritisPneumonia/lower respiratory tract infection | Upper respiratory tract infection |
| People (all ages) living in crowded households | Hepatitis A | |||
| Second-hand smoke (SHS) exposure | Maternal smoking and/or exposure to SHS | Babies exposed to SHS through maternal smoking | Sudden unexpected death in infancy (SUDI) | |
| Maternal exposure to SHS during pregnancy | Babies exposed to SHS in utero (non-smoking mother exposed to SHS) | Small for gestational age (low birthweight) | Preterm delivery | |
| Second-hand smoke exposure in the home | Children exposed to SHS in the home | Asthma | Meningococcal disease | |
| Non-smoking adults exposed to SHS in the home | Ischaemic heart disease | Asthma (induction, exacerbation) | ||
| Damp, mouldy, cold houses | Damp and mould | Children living in damp and mouldy houses | Asthma exacerbation | Respiratory infections, bronchitis |
| Adults living in damp and mouldy houses | Asthma exacerbation | |||
| Unsafe home environment | Physical hazards in the home | Children | Falls | Drowning |
| Hazardous chemicals in the home | Children | Poisonings |
Potential environmental health indicators identified for the indoor environment (n = 24).
| Potential Indicator | Data Source | Meet All Criteria? | Indicator Selection Criteria | Comments | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Data Availability | Scientifically Valid | Sensitive to Change | Consistent | Comparable | Methodologically Sound | Intelligible and Easily Interpreted | Able to Be Disaggregated | Timely | ||||
|
| ||||||||||||
| People living in crowded households | Census | Yes | √ | √ | √ | √ | √ | √ | √ | √ | √ | Both children and total population are important to monitor. |
| People exposed to SHS in the home | NZHS | Yes | √ | √ | √ | √ | √ | √ | √ | √ | √ | Both children and adults are important to monitor. |
| Mothers smoking at two weeks postnatal | Maternity | Yes | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
| People living in damp and mouldy houses | Census (living in damp and mouldy houses) | No | × | √ | √ | √ | √ | √ | √ | √ | √ | Data about people living in damp and mouldy houses are not currently available but will be available in 2019 from the 2018 Census. Not known if this data will be collected again. |
| NZGSS | No | × | √ | √ | √ | √ | √ | √ | ? | ? | Only adults are covered, not children. Data collected twice (2010 and 2014)—unknown if it will be collected again. | |
| Census (no source of home heating) | No | √ | × | √ | √ | √ | √ | √ | √ | √ | Data about households with no source of home heating could be a proxy for cold houses, which are associated with damp and mouldy housing. However, this is not a good measure of cold houses (for example, some people do not use available home heating due to cost) or damp and mouldy houses and will mis-measure the true value. | |
|
| ||||||||||||
| Lower respiratory tract infection hospitalisations in children | NMDS | Yes | √ | √ | √ | √ | √ | √ | √ | √ | √ | Evidence for 0–1 years (SHS) and 0–5 years (household crowding) |
| Bronchiolitis from RSV hospitalisations | NMDS | Yes | √ | √ | √ | √ | √ | √ | √ | √ | √ | Bronchiolitis is also included in the definition for lower respiratory tract infection. |
| NMDS | No | √ | √ | × | √ | √ | √ | √ | √ | √ | Hospitalisations are for sequelae of | |
| Gastroenteritis hospitalisations | NMDS | Yes | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
| Tuberculosis hospitalisations | NMDS | Yes | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
| Meningococcal disease notifications | EpiSurv | Yes | √ | √ | √ | √ | √ | √ | √ | √ | √ | Evidence for 0–16 years (household crowding) and suggested link with SHS |
| Hepatitis A hospitalisations | NMDS | Yes | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
| NMDS | Yes | √ | √ | √ | √ | √ | √ | √ | √ | √ | One of the ICD-10-AM codes for Hib disease (J14) is also included in the definition for lower respiratory tract infection. | |
| Asthma prevalence in children | NZHS | Yes | √ | √ | √ | √ | √ | √ | √ | √ | √ | Evidence for 0–14 years (SHS, dampness/mould). |
| Asthma hospitalisations in children | NMDS | Yes | √ | √ | √ | √ | √ | √ | √ | √ | √ | Evidence for 0–14 years (SHS, dampness/mould). Asthma hospitalisations are a proxy for asthma exacerbation. |
| Sudden unexpected death in infancy (SUDI) | MoH | Yes | √ | √ | √ | √ | √ | √ | √ | √ | √ | Strong evidence for mothers smoking after birth |
| Otitis media/grommets hospitalisations in children | NMDS | Yes | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
| Ischaemic heart disease hospitalisations/deaths in non-smoking adults | NMDS/Mort | No | × | √ | × | √ | √ | √ | √ | √ | √ | Difficult to get data for non-smokers. Lag-time of 1–5 years after exposure. |
| Stroke hospitalisations/deaths in non-smoking adults | NMDS/Mort | No | × | √ | × | √ | √ | √ | √ | √ | √ | Difficult to get data for non-smokers. Lag-time of 1–5 years after exposure. |
| Lung cancer registrations/deaths in non-smoking adults | Cancer/Mort | No | × | √ | × | √ | √ | √ | √ | √ | √ | Difficult to get data for non-smokers. Lag-time of 10–20 years after exposure. |
| Small for gestational age (low birthweight) | Maternity | Yes | √ | √ | √ | √ | √ | √ | √ | √ | √ | Data are available for proportion of all babies born at term gestation who are small for their gestational age. |
| Unintentional injuries in the home in children | NMDS | Yes | √? | √ | √ | √ | √ | √ | √ | √ | √ | The data exists, but it depends whether location data is robust enough to include. Needs further investigation. |
| Falls in the home in children | NMDS | Yes | √? | √ | √ | √ | √ | √ | √ | √ | √ | |
| Burns in the home in children | NMDS | Yes | √? | √ | √ | √ | √ | √ | √ | √ | √ | |
| Poisonings in the home in children | NMDS | Yes | √? | √ | √ | √ | √ | √ | √ | √ | √ | |
Abbreviations: √ = Meets criteria; × = Does not meet criteria; SHS = second-hand smoke; Census = New Zealand Census of Populations and Dwellings; NZHS = New Zealand Health Survey; Maternity = New Zealand Maternity Clinical Indicators; NZGSS = New Zealand General Social Survey; EpiSurv = EpiSurv notifiable disease surveillance database; MoH = Ministry of Health publications; NMDS = National Minimum Dataset (hospitalisations data); Mort = New Zealand Mortality Collection; Cancer = New Zealand Cancer Registry; ICD-10-AM = International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification.
Assessment of health indicators for indoor environment, by public health impact criteria.
| Potential Health Indicator | Health Condition (Relating to Potential Health Indicator) | Age Group for Attributable Burden Evidence | Met All Other Indicator Selection Criteria? | Public Health Impact Criteria | Recommend | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| (i) Proportion Attributable (PAF, %) | (i) Attributable Burden | (ii) Severity of Impact | (iv) Vulnerable Populations Affected and/or Inequalities | (iii) Multiple Exposures | (v) Specific Policy Relevance of Indicator | |||||
| Household Crowding Indicators | Annual Attributable Hospitalisations (2007–2011) [ | |||||||||
| Lower respiratory tract infection hospitalisations | Lower respiratory infections/pneumonia | 0–5 years | Yes | 10% | 669 | Short-term, rarely fatal | Children, Māori, Pacific | Yes | Core | |
| Bronchiolitis hospitalisations | Bronchiolitis from RSV | 0–3 years | Yes | 16% | 644 | Short-term, rarely fatal | Children, Māori, Pacific | |||
| Hospitalisations for sequelae of | 0+ years | Yes | 8% | 102 | Long-term, can lead to other health problems; not all | Māori, Pacific peoples | ||||
| Gastroenteritis hospitalisations | Gastroenteritis | 0–5 years | Yes | 2% | 42 | Short-term, rarely fatal in New Zealand | Children | |||
| Tuberculosis notifications | Tuberculosis | 15+ years | Yes | 19% | 22 | Long-term; takes a long time to treat and cure; can have some sequelae. | Māori adults, Pacific adults | In New Zealand, little disease transmission takes place within-country | ||
| Meningococcal disease notifications | Meningococcal disease | 0–16 years | Yes | 15% | 5 | Can be fatal and may cause long-term disability | Children, Māori, Pacific peoples | Yes (second-hand smoke Level 2) | An epidemic in the 2000s led to national vaccination campaign | Core |
| Hepatitis A hospitalisations | Hepatitis A | 0+ years | Yes | 5% | 1 | |||||
| Hospitalisations for | 0–6 years | Yes | 10% | 0.7 | Children | |||||
| Second-Hand Smoke Exposure Indicators | Attributable DALYs (2006) [ | |||||||||
| Ischaemic heart disease hospitalisations/deaths in non-smoking adults | Ischaemic heart disease | 15+ years non-smokers | No | 1.5% | 1033 | Can be fatal | ||||
| Stroke hospitalisations/deaths in non-smoking adults | Stroke | 35+ years non-smokers | No | 1.3% | 389 | Can be fatal, cause long-term disability | ||||
| Lung cancer registrations/deaths in non-smoking adults | Lung cancer | 15+ years non-smokers | No | 2.2% | 96 | Often fatal | ||||
| Sudden unexpected death in infancy (SUDI) | SUDI | 0 years | Yes | 11.3% | 596 | Fatal | Children, Māori | SUDI prevention activities are funded in New Zealand | Core | |
| Asthma prevalence | Asthma (onset, ever had asthma) | 0–14 years | Yes | 3.1% | 93 | Long-term, rarely fatal | Children, Māori | Yes | Core | |
| Lower respiratory tract infection hospitalisations | Lower respiratory tract infections | 0–1 years | Yes | 3.1% | 42 | Short-term, rarely fatal | Children, Māori | Yes | Core | |
| Otitis media hospitalisations (acute; grommets) | Otitis media | 0–14 years | Yes | 2.6% | 31 | Short-term | Children, Māori | |||
| Small for gestational age | Low birthweight at term | 0 years | Yes | 2.5% | 6 | Can lead to long-term effects | Children, Māori | |||
| Damp and Mouldy Housing Indicator | Annual Attributable Hospitalisations (2015) | |||||||||
| Asthma hospitalisations | Asthma exacerbation | 0–14 years | Yes | 15% | 537 | Long-term illness | Children, Māori, Pacific | Yes | Core | |
| Unsafe Environments Indicator | Annual Impacts (1989–1998) [ | |||||||||
| Unintentional injuries hospitalistations (for injuries occurring in the home) | Unintentional injuries in the home | 0–4 years | Yes | Not available | 39 deaths; 2464 hospital admissions (total numbers) | Can be fatal, may cause long-term disability | Children | Core, but subject to further investigation of data quality for location data | ||
Final set of core environmental health indicators for indoor environment.
| Indicator | Age Group | Data Source | Design Details | Latest Results for New Zealand (Year of Data) |
|---|---|---|---|---|
|
| ||||
| Proportion of people living in crowded households | 0–14 years, Total population | Census | People living in a house requiring one or more additional bedrooms, according to the Canadian National Occupancy Standard [ | 10% of total population; 16% of children; 25% of Māori children; and 43% of Pacific children (2013) |
| Proportion of children and non-smoking adults exposed to second-hand smoke in the home | 0–14 years | New Zealand Health Survey | People reporting that someone smoked inside the house [ | 5.0% of children; 3.7% of non-smoking adults; and 9.2% of Māori children (2012/13) |
| Mothers smoking at two weeks postnatal | All mothers who gave birth in that year | New Zealand Maternity Clinical Indicators | Mothers who reported that they smoked at two weeks after birth, among all mothers who reported a smoking status at two weeks after birth [ | 12% of mothers; and 32% of Māori mothers (2015) |
|
| ||||
| Prevalence of asthma in children | 2–14 years | New Zealand Health Survey publications | Children aged 2–14 years who have been diagnosed by a doctor as having asthma, and who are currently using inhalers, medicine, tablets, pills, or other medication for it [ | 16.6% of children; 24.0% of Māori children; and 17.4% of Pacific children (2015/2016) |
| Asthma hospitalisations in children | 0–14 years | National Minimum Dataset | Acute and semi-acute hospitalisations with asthma (ICD-10AM J45–J46) or wheeze (R06.2) as the primary diagnosis, for children aged 0–14 years. Analyses excluded overseas visitors, deaths, and transfers within and between hospitals. Wheeze is included as there is evidence that paediatricians are more likely to diagnose suspected asthma as wheeze for younger children in New Zealand [ | 682 hospitalisations per 100,000 children; 838 per 100,000 (Māori); and 1324 per 100,000 (Pacific) (2016) |
| Lower respiratory tract infection hospitalisations in children | 0–4 years | National Minimum Dataset | Acute and semi-acute hospitalisations with pneumonia (ICD-10AM J12–J16, J18), bronchitis (J20), bronchiolitis (J21) or unspecified acute lower respiratory tract infection (J22) as the primary diagnosis, for children aged 0–4 years. | 3050 hospitalisations per 100,000 children; 4254 per 100,000 (Māori); and 6711 per 100,000 (Pacific) (2016) |
| Meningococcal notifications | 0–14 years | EpiSurv | Notifications of meningococcal disease, in children aged 0–14 years. | 35 notifications; highest rates in Māori and Pacific children (2016) |
| Sudden unexpected death in infancy (SUDI) | 0 years | Fetal and infant deaths publication | Deaths in children aged under one year of age (<1 year old) with an underlying cause of death in the following ICD-10AM codes: R95, R96, R98, R99, W75, W78, W79. Rates are presented per 1000 live births [ | 45 deaths; highest rate in Māori babies (2014) |